Allosteric therapy discovery and development
The company leads the discovery and development of next-generation allosteric therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Gain Therapeutics is a clinical-stage biotechnology company focused on discovering and developing next-generation allosteric therapies.
The company discovers allosteric small molecule modulators that can restore or disrupt protein function. Gain uses its Magellan platform in drug discovery for difficult-to-treat disorders, including neurodegenerative diseases, rare genetic disorders and oncology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company leads the discovery and development of next-generation allosteric therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.